Did the source data have SNOMED code values?
Thanks
Jonathan
On 23 Aug 2014, at 19:30, Webster Craig <[log in to unmask]> wrote:
> Don't know if this will make it easier to view a summary of the records but Ive taken them XML and transformed it to a web page at http://secret-garden-2763.herokuapp.com
> The source code of which is at https://github.com/cwebster/nlmc
> It should be relatively easy to change the render to display other information and add search
> Cheers
> Craig
> ________________________________
> From: IT working group of the Association for Clinical Biochemistry and Laboratory Medicine [[log in to unmask]] on behalf of OConnor John (ROYAL DEVON AND EXETER NHS FOUNDATION TRUST) [[log in to unmask]]
> Sent: 20 August 2014 12:09
> To: [log in to unmask]
> Subject: Path Catalogue
>
>
> ---
> This message was sent from an email address external to NHSmail but gives the appearance of being from an NHSmail (@nhs.net) address. The recipient should verify the sender and content before acting upon information contained within.
>
> The identified sender is [log in to unmask]
> ---
>
> Chaps
> Just want to pick your brains
> I am guessing that the only format the National Path Catalogue is currently in is XML?
> At least that’s the version that can be found below
> https://isd.hscic.gov.uk/trud3/user/authenticated/group/0/pack/1/subpack/77/releases
> I am having discussions with our CCG commissioners about the allocation of tests to different path disciplines in order to work out under which tariff they should be charged under. The guidance in the 2013/2014 Payment by results publication as far as path goes is as below
> The bit in red is relevant
> Navigating through the XML is a little complex, but then there is ambiguity around which disciplines a test is ascribed to. So for example Protein fractionation (electrophoresis) is listed as both biochem and immunology, the ref tariff for biochem is about £1:50 and immunology is £20 so it makes a heck of a difference where its allocated.
> Also, has anyone a clue as to what the integrated (Chem/Haem/Imm) reference tariff is?. This would better reflect the fact we run an combined blood sciences lab here at the RDE.
> Has anyone else come across this issue and what are you doing to deal with it?.
> Cheers
> John
>
>
> Pathology services
>
> 280. Costs and activity for the following pathology services should be submitted based on the number of tests, with the number of requests for pathology investigation64 required as a memorandum:
>
>
>
> (a) cytology (excluding cervical screening programmes)
>
> (b) histopathology and histology
>
> (c) integrated blood sciences services (including clinical biochemistry, haematology and immunology)
>
> (d) clinical biochemistry
>
> (e) haematology
>
> (f) immunology
>
> Reference costs guidance for 2013-14: A draft for NHS feedback 65
>
>
>
> (g) microbiology (including bacteriology, virology and mycology)
>
> (h) phlebotomy
>
> (i) other.
>
>
>
> 281. Trusts may submit costs against integrated blood sciences, or separately against clinical biochemistry, haematology and immunology, but must not submit costs against both.
>
>
>
> 282. Trusts should refer to the National Laboratory Medicine Catalogue, a catalogue of pathology tests designed to support consistent, standardised reporting, which is available via TRUD (paragraph 3).
>
>
>
> 283. The Department, working with NHS Midlands and East, has also produced a toolkit to support commissioning of community (i.e. direct access) pathology services65. Whilst primarily intended for commissioners, providers of pathology services may also find some of the tools helpful.
>
>
>
> 284. Direct access pathology costs will vary depending on whether the service is hospital or community based. Care should be taken to include the entire cost, including costs incurred in the transportation of samples where appropriate.
>
>
>
> ********************************************************************************************************************
>
> This message may contain confidential information. If you are not the intended recipient please inform the
> sender that you have received the message in error before deleting it.
> Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:
> to do so is strictly prohibited and may be unlawful.
>
> Thank you for your co-operation.
>
> NHSmail is the secure email and directory service available for all NHS staff in England and Scotland
> NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and GSi recipients
> NHSmail provides an email address for your career in the NHS and can be accessed anywhere
>
> ********************************************************************************************************************
|